Financhill
Back

Tabula Rasa HealthCare Quote, Financials, Valuation and Earnings

Tabula Rasa HealthCare Price Quote

$10.30

Tabula Rasa HealthCare Key Stats

Sell
42
Tabula Rasa HealthCare (TRHC) is a Sell

Day range:
$10.29 - $10.31
52-week range:
$3.15 - $10.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.76
P/B ratio:
0%

Volume:
200.2K
Avg. volume:
396.5K
1-year change:
133.56%
Market cap:
$278.7M
Revenue:
$299.5M
EPS:
$-3.85

How Much Does Tabula Rasa HealthCare Make?

Is Tabula Rasa HealthCare Growing As A Company?

Tabula Rasa HealthCare Stock Price Performance

What Is Tabula Rasa HealthCare 52-Week High & Low?

Tabula Rasa HealthCare Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Tabula Rasa HealthCare?

Is Tabula Rasa HealthCare Cash Flow Positive?

  • What Is TRHC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$5.1M
  • What Is Tabula Rasa HealthCare’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$59.8M
  • What Is Tabula Rasa HealthCare’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $104.5M

Tabula Rasa HealthCare Return On Invested Capital

  • Is Management Doing A Good Job?
    TRHC return on invested capital is -33.71%
  • What Is Tabula Rasa HealthCare Return On Assets?
    ROA measures how assets are converting to revenues and is -24.06%
  • What Is TRHC Return On Equity?
    ROE is a measure of profitability and is 0%

Tabula Rasa HealthCare Earnings Date & Stock Price

Tabula Rasa HealthCare Competitors

Tabula Rasa HealthCare Dividend Yield

Data Unavailable

Tabula Rasa HealthCare Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 119.6%
Revenue: 24.02% 1.32%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 10.50
Upside from Last Price: 1.94%

Major Shareholders

  • How many TRHC shares are owned by institutional investors?
    26.8M TRHC shares are owned by institutional investors
  • How many TRHC shares are owned by insiders?
    3.3M TRHC shares are owned by insiders